These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1971 related articles for article (PubMed ID: 31243897)

  • 1. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
    Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
    Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
    Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
    Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
    Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
    J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
    Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
    J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
    Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
    Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
    Fang F; Wang X; Li Z; Ni K; Xiong C
    Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
    Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
    Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
    Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA m6A modification, signals for degradation or stabilisation?
    Wei G
    Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling.
    Zhang C; Lin X; Zhao Q; Wang Y; Jiang F; Ji C; Li Y; Gao J; Li J; Shen L
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):329-342. PubMed ID: 31912229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 99.